JP2024512573A5 - - Google Patents

Info

Publication number
JP2024512573A5
JP2024512573A5 JP2023558552A JP2023558552A JP2024512573A5 JP 2024512573 A5 JP2024512573 A5 JP 2024512573A5 JP 2023558552 A JP2023558552 A JP 2023558552A JP 2023558552 A JP2023558552 A JP 2023558552A JP 2024512573 A5 JP2024512573 A5 JP 2024512573A5
Authority
JP
Japan
Prior art keywords
cells
chimeric polypeptide
cell
recombinant
polypeptide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023558552A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024512573A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/021352 external-priority patent/WO2022204151A1/en
Publication of JP2024512573A publication Critical patent/JP2024512573A/ja
Publication of JP2024512573A5 publication Critical patent/JP2024512573A5/ja
Pending legal-status Critical Current

Links

JP2023558552A 2021-03-23 2022-03-22 カスタム抗原誘導性転写制御のための合成膜間タンパク質分解受容体 Pending JP2024512573A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163164995P 2021-03-23 2021-03-23
US63/164,995 2021-03-23
PCT/US2022/021352 WO2022204151A1 (en) 2021-03-23 2022-03-22 Synthetic intermembrane proteolysis receptors for custom antigen-induced transcriptional regulation

Publications (2)

Publication Number Publication Date
JP2024512573A JP2024512573A (ja) 2024-03-19
JP2024512573A5 true JP2024512573A5 (https=) 2025-03-28

Family

ID=83397827

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023558552A Pending JP2024512573A (ja) 2021-03-23 2022-03-22 カスタム抗原誘導性転写制御のための合成膜間タンパク質分解受容体

Country Status (7)

Country Link
US (1) US20240181057A1 (https=)
EP (1) EP4314038A4 (https=)
JP (1) JP2024512573A (https=)
CN (1) CN117255799A (https=)
AU (1) AU2022244245A1 (https=)
CA (1) CA3213044A1 (https=)
WO (1) WO2022204151A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024140778A1 (zh) * 2022-12-27 2024-07-04 科济生物医药(上海)有限公司 Nkg2d工程化细胞及其组合物
AU2024260837A1 (en) * 2023-04-25 2025-10-16 Arsenal Biosciences, Inc. Novel receptors for transcription regulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020199218A1 (en) * 1999-08-19 2002-12-26 Daphne Goring Proline-rich extensin-like receptor kinases
KR102624023B1 (ko) * 2015-02-24 2024-01-11 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 결합-촉발된 전사 스위치 및 이들의 이용 방법
MX2018008345A (es) * 2016-01-11 2018-12-06 Univ Leland Stanford Junior Proteínas quiméricas y métodos de inmunoterapia.
CN109843929B (zh) * 2016-08-23 2024-07-05 加利福尼亚大学董事会 蛋白水解可切割的嵌合多肽及其使用方法
US12410417B2 (en) * 2016-10-24 2025-09-09 Northwestern University Modular extracellular sensor architecture for regulating genes
WO2019164979A1 (en) * 2018-02-21 2019-08-29 Cell Design Labs, Inc. Chimeric transmembrane receptors and uses thereof
WO2020014270A1 (en) * 2018-07-10 2020-01-16 The Regents Of The University Of California Biomolecule coated particles and films and uses thereof
CN114728174A (zh) * 2019-09-24 2022-07-08 加利福尼亚大学董事会 具有异源跨膜结构域的受体
AU2020355031A1 (en) * 2019-09-24 2022-05-19 The Regents Of The University Of California Notch receptors with hinge domain

Similar Documents

Publication Publication Date Title
JP2022548796A5 (https=)
FI4034252T3 (fi) Saranadomeenin sisältäviä Notch-reseptoreita
JP2021512635A5 (https=)
Chen et al. Bispecific antibodies in cancer immunotherapy
JP2024511423A5 (https=)
JP2021518142A5 (https=)
JP2021502104A5 (https=)
JP2022525478A5 (https=)
JP2020516287A5 (https=)
JP2019537433A5 (https=)
JP2019523630A5 (https=)
JP2015527070A5 (https=)
WO2022222910A1 (zh) 靶向gprc5d的抗体及其用途
JP2024512573A5 (https=)
JP2022542559A5 (https=)
JP2024534471A5 (https=)
WO2022170280A2 (en) Novel anti-cd24 antibodies
JP2024546999A5 (https=)
JP2025106309A5 (https=)
WO2023274303A1 (zh) 调控细胞生理活动的嵌合多肽
JP2023521519A5 (https=)
WO2022111405A1 (zh) 靶向Claudin18.2的抗体及其用途
Hayashi et al. A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells
CN114437214B (zh) 靶向lir1的抗体及其用途
US20230399627A1 (en) Vector genetically engineered with chimeric antigen receptor and against two or more targets and application thereof